PARTNERINGContact us for information
Navigen's substantial experience in D-peptide drug discovery and optimization and our proprietary assets, including our custom phage libraries and bioinformatics tools, position us to be a world leader in D-peptide discovery and development. We plan to work on new D-peptide targets independently as well as collaboratively with global partners. We anticipate out-licensing in-house D-peptide programs no later than after human proof of concept. For jointly developed programs, Navigen's preference is for our partner to take over development just prior to IND-enabling studies.
For information about collaboration and partnering opportunities with Navigen, please contact Vimal Swarup at 801-587-1427 or